Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
5(45%)
Results Posted
33%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
1
9%
Ph not_applicable
6
55%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

11

all time

Status Distribution
Active(7)
Completed(3)
Terminated(1)

Detailed Status

Recruiting5
Completed3
Enrolling by invitation2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
5
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (14.3%)
N/A6 (85.7%)

Trials by Status

terminated19%
recruiting545%
completed327%
enrolling_by_invitation218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
11